Showing results (1751-1760 of 1,912) with videos related to

Sort By:
Pageof 192
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 2, 2021
A synthetically lethal nanomedicine delivering novel inhibitors of polynucleotide kinase 3'-phosphatase (PNKP) for targeted therapy of PTEN-deficient colorectal cancerSams M A Sadat, Igor M Paiva, Zahra Shire, et al.
Journal of Hepatology|January 2, 2007
Health-related quality of life in patients with chronic hepatitis C and advanced fibrosisHerbert L Bonkovsky, Kristin K Snow, Peter F Malet, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 9, 2026
Safety and Efficacy of Eflornithine in Patients with Gastric Precancerous Lesions: A Double-blinded, Randomized Clinical TrialDouglas R Morgan, Ricardo L Dominguez, Dalton A Norwood, et al.
Contemporary Clinical Trials Communications|March 27, 2023
Virtual delivery of improvisational movement and social engagement interventions in the IMOVE trial during the COVID-19 pandemicJason T Fanning, Rebecca Barnstaple, Phyllis Babcock, et al.
World Neurosurgery|August 3, 2017
Congenital Malformations of the Central Nervous System in Rural Western Honduras: A 6-Year Report on TrendsDagoberto Estevez-Ordonez, Michael C Dewan, Michael J Feldman, et al.
Hepatology (Baltimore, Md.)|April 1, 2024
Management of coagulopathy among patients with cirrhosis undergoing upper endoscopy and paracentesis: Persistent gaps and areas of consensus in a multispecialty DelphiElliot B Tapper, Matthew A Warner, Rajesh P Shah, et al.
Current Medical Research and Opinion|January 11, 2023
A consensus viewpoint on the role of direct factor Xa inhibitors in the management of cancer-associated venous thromboembolism in the UKAlexander T Cohen, Gary Benson, Charlotte A Bradbury, et al.
Human Genetics|May 27, 2016
Epigenetic and genetic variation in GATA5 is associated with gastric disease riskRafal S Sobota, Nuri Kodaman, Robertino Mera, et al.
Cellular Immunology|July 21, 2009
Cytotoxic T cell immunity against the non-immunogenic, murine, hepatocellular carcinoma Hepa1-6 is directed towards the novel alternative form of macrophage colony stimulating factorLisheng Ge, Jian Gang Zhang, Christina A Samathanam, et al.
Hepatology (Baltimore, Md.)|January 6, 2022
Patient-reported outcomes in HCC: A scoping review by the Practice Metrics Committee of the American Association for the Study of Liver DiseasesMarina Serper, Neehar D Parikh, Grace Thiele, et al.
Pageof 192